Product Information
Pegloticase is a PEGylated urate oxidase enzyme used to treat chronic granulomatous disease. It is also a methyltransferase inhibitor that prevents the activation of bacterial enzymes, such as cytosine-guanine dinucleotide phosphate (CpG) methyltransferase. This enzyme catalyses the methylation of CpG sites on DNA, which are important for maintaining normal gene expression. Pegloticase has been shown to be effective in reducing the activity of inflammatory bowel disease and rheumatoid arthritis. It also has been shown to have pharmacological effects on congestive heart failure, hypersensitivity syndrome, and bowel diseases due to its anti-inflammatory properties. Pegloticase has not been studied in patients with hepatic impairment or taking nonsteroidal anti-inflammatory drugs.
Chemical properties
Technical inquiry about: 3D-FP177247 Pegloticase
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
